Responses
Clinical/translational cancer immunotherapy
Original research
Novel platform leveraging electronic medical record (EMR) to triage patients admitted with high-grade immune-related adverse events (irAEs) to the immune-toxicity (ITOX) service
Compose a Response to This Article
Other responses
No responses have been published for this article.